Apollo Endosurgery, Inc.: 10-K filed 2016-03-22
What Apollo Endosurgery, Inc. reported in its annual report filed 2016-03-22 (fiscal FY 2015): 29 published measures, 60 facts as tagged in accession 0001558370-16-004287.
This filing
- Form
- 10-K (annual report)
- Filed
- 2016-03-22
- Fiscal period
- fiscal FY 2015
- Accession
- 0001558370-16-004287 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Apollo Endosurgery, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 11,612,445 | USD | |
| At 2014-12-31 | 20,958,170 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 1,080,454 | USD | |
| At 2014-12-31 | 5,141,744 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 10,531,991 | USD | |
| At 2014-12-31 | 15,816,426 | USD | |
| At 2013-12-31 | 9,968,173 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 8,889,616 | USD | |
| At 2014-12-31 | 17,282,325 | USD | |
| At 2013-12-31 | 11,851,639 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 21,117 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 105,611 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 1,599,763 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 5,080,463 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | -76,043,515 | USD | |
| At 2014-12-31 | -66,033,209 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 0 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 149,271 | USD | |
| At 2014-12-31 | 221,148 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 953,019 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 1,236,274 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | -10,860,358 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -17,805,069 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 9,253,885 | USD | |
| At 2014-12-31 | 18,422,763 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 1,080,454 | USD | |
| At 2014-12-31 | 4,256,115 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 294,010 | USD | |
| At 2014-12-31 | 2,865,165 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 2,132,129 | USD | |
| At 2014-12-31 | 2,236,909 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 6,988 | USD | |
| At 2014-12-31 | 727,178 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 12,460,121 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 22,885,532 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 8,513,974 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 18,126,701 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 33,138,598 | shares | |
| At 2014-12-31 | 19,224,708 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 787,646 | USD | |
| At 2014-12-31 | 769,482 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 638,375 | USD | |
| At 2014-12-31 | 548,334 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 77,160 | USD | |
| At 2014-12-31 | 77,350 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 204,237 | USD | |
| At 2014-12-31 | 383,623 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 357,281 | USD | |
| At 2014-12-31 | 413,260 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | -10,010,306 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -16,555,051 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 3,946,147 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 4,758,831 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 466,988 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 216,088 | USD | 365 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | 52 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 18 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-12-31 | -720,190 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -582,859 | USD | 365 |
Inspect the source
- Entity
- Apollo Endosurgery, Inc. / CIK 0001251769
- Captured
- SEC response SHA-256
308ca5de51c5ff3a6ebe7ea06081848be77e7c3a8b2c9b2bce1d856f60a70fce
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001251769.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))